AI in life sciences presents key opportunities in drug discovery, personalized medicine, and diagnostics by leveraging vast ...
SAN FRANCISCO (KRON) – As the use of artificial intelligence becomes a more popular tool in drug research, a scientific software company aims to one day use the technology to predict future medicines.
This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...
(Reuters) -U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical, deepening their use of artificial intelligence ...
With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant ...
Artificial intelligence is accelerating drug development and lowering costs across the pharmaceutical industry, potentially ...
Integrating computational models (SELFormer, AlphaFold2, scConGraph, PROTAC-RL) with multi-omics data to validate historically undruggable targets (e.g., KRAS via ...
Artificial intelligence is quietly reshaping the pharmaceutical industry and the financial upside could be enormous.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results